Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/25 17:10 | 2/19/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | 1 | S | -19 | 4.41 | 0 | -4 | 220 | D | |||||||||||||||
2/21/25 17:09 | 2/19/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | See Tai Sandi | NY | O | Chief De | 1 | S | -7 | 4.41 | 0 | -1 | 54 | D | |||||||||||||||
2/21/25 17:09 | 2/19/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | Adler Eric | NY | O | Chief Me | 1 | S | -10 | 4.41 | 0 | -2 | 68 | D | |||||||||||||||
2/21/25 17:08 | 2/19/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | Robertson Jenny | NY | O | GC | 1 | S | -9 | 4.41 | 0 | -2 | 58 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |